-
Posted by
Two Blokes Jun 6 -
Filed in
Stock
-
10 views
UnitedHealth's share price decline presents a compelling value opportunity for long-term dividend investors, despite recent negative headlines and revised 2025 guidance. Fundamentals remain strong with solid revenue and EPS growth, a healthy balance sheet, and continued dividend increases, even amid sector-wide headwinds. Management is focused on cost controls and operational efficiency, aiming for a return to double-digit EPS growth in 2026 and beyond.
